Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

NCT01508026 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4161

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage 1 Hypertension
Stage 2 Hypertension

Interventions

DRUG: Nebivolol and Valsartan 1
DRUG: Nebivolol and Valsartan 2
DRUG: Nebivolol and Valsartan 3
DRUG: Nebivolol 1
DRUG: Nebivolol 2
DRUG: Valsartan 1
DRUG: Valsartan 2
DRUG: Placebo

Sponsor

Forest Laboratories